Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension
Conditions
Keywords
latent
Brief summary
Severe CTEPH leads to an impaired physical capacity and a restricted quality of life and poor prognosis. Pulmonary endarterectomy represents the best choice as therapy, when the thrombi are located in the central pulmonary vessels and therefore can be operated. By this operation the pulmonary artery pressure can be normalised and the patients' survival improved. Up to now, after successful endarterectomy patients only receive anticoagulation. Despite operation many patients remain symptomatic and are restricted in their physical capacity. Therefore a hypothesis of this project is that most of the patients, even after successful operation, show peripheral vascular remodelling with a ventilation-perfusion mismatch and elevated pulmonary pressure during exercise. In this study we aim to analyse how many patients with CTEPH after endarterectomy show elevated pulmonary artery pressures at rest or during exercise and are limited in their physical capacity, hemodynamics, oxygen uptake and quality of life and need further therapy. Another aim is to examine whether exercise and respiratory therapy may improve the patients postoperatively. Therefore 30 patients with CTEPH \> six months after endarterectomy, with ongoing restricted exercise capacity shall be included. After baseline examination in the University hospital Heidelberg the patients receive exercise and respiratory therapy for three weeks. The patients will receive further examinations at the end of rehabilitation after 3 weeks and after 15 weeks. All examinations include medical history, family history, physical examination, ECG and echocardiography at rest and during exercise, cardiopulmonary exercise testing, assessment of the respiratory muscle strength, the SF-36 questionnaire for quality of life, laboratory testing and MRI. Rehabilitation will be conducted in the clinic for rehabilitation Koenigstuhl, Heidelberg. Participants will be randomised into two groups, a control group receiving a conventional therapy for three weeks, in which physical exertion is to be avoided and a training group with additional exercise and respiratory therapy.
Interventions
BEHAVIORALexercise and respiratory therapy
exercise and respiratory therapy for three weeks in-hospital and 15 weeks at home
OTHERsedentary control group
control group with no specific training
Sponsors
Heidelberg University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* A Screening 1. Informed consent 2. Men and women 18 - 75 years 3. Patients ≥ 6 months after endarterectomy because of chronic thromboembolic pulmonary hypertension (CTEPH) * B Training See A + all patients who showed a restricted physical capacity in the screening: * Latent pulmonary hypertension * Restricted physical capacity
Exclusion criteria
1. Pregnancy or lactation 2. Change in medication during the last 2 months 3. Patients with signs of right heart decompensation 4. Disease which affects the gait 5. Unclear diagnosis 6. Acute illness, infection, fever 7. Severe lung diseases with FEV1 \<50% and TLC\< 70% of reference
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in 6-Minute walking test | after 3 and 15 weeks compared to baseline |
| Change in quality of life | baseline and 15 weeks |
Secondary
| Measure | Time frame |
|---|---|
| noninvasive hemodynamic parameters | baseline, 3 and 15 weeks |
| change of systolic pulmonary arterial pressure at rest and during exercise | baseline, 3 and 15 weeks |
| change of WHO functional class | baseline, 3 and 15 weeks |
| physical capacity in the ergometer test | baseline, 3 and 15 weeks |
| change of respiratory muscle function | baseline and 15 weeks |
| change of NTproBNP | baseline, 3 and 15 weeks |
| change of perfusion parameters (MRI) | baseline, 3 and 15 weeks |
| change of lung function during 6-minute walking test | baseline, 3 and 15 weeks |
Countries
Germany
Contacts
Primary ContactEkkehard Gruenig, MD
Outcome results
None listed